Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 465557012 | Zalcitabine 0.375mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 718134018 | Zalcitabine 0.375mg tablet (substance) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1190517012 | Zalcitabine 0.375mg tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 2153233017 | Zalcitabine 375microgram tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 2160860015 | Zalcitabine 375microgram tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3472579019 | Zalcitabine 375 microgram/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3472580016 | Product containing zalcitabine 375 microgram/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3484116017 | Product containing zalcitabine 375 microgram/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3566651010 | Product containing only zalcitabine 375 microgram/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3566652015 | Product containing only zalcitabine 375 microgram/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3684043018 | Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3684044012 | Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3684045013 | Zalcitabine 375 microgram oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 56980701000001117 | Zalcitabine 375microgram tablets | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Is a | Product containing zalcitabine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Has active ingredient | Zalcitabine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Is a | Product manufactured as oral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Has active ingredient | Zalcitabine | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Has basis of strength substance | Zalcitabine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Has presentation strength numerator value | 375 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Has presentation strength numerator unit | microgram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Is a | Product containing zalcitabine in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Has precise active ingredient | Zalcitabine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Is a | Product containing only zalcitabine in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Plays role | Antiretroviral therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Is a | Zalcitabine | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Oral route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | tablet.oral ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Has active ingredient | Zalcitabine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | VMP non-availability indicator | Not available | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Has specific active ingredient | Zalcitabine | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Has dispensed dose form | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Zalcitabine 0.375mg tablet - product | Is a | False | Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Hivid 375microgram tablets (Roche Products Ltd) | Is a | True | Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Zalcitabine 375microgram tablets 100 tablet | Is pack of | False | Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Zalcitabine 375microgram tablets 100 tablet | Has VMP | True | Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets